Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Thursday, November 21, 2024.
MoonLake Immunotherapeutics - Class A Ordinary Shares (NASDAQ:MLTX)
Bull Market Weakness (+75) - MLTX is showing signs of short-term weakness, but still remains in the confines of a long-term uptrend. Keep an eye on MLTX as it may be in the beginning stages of a reversal.
Is it time to buy, sell, or avoid MLTX?
MarketClub looks at technical strength and momentum to determine if the timing is right for MLTX.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for MLTX
The long-term trend has been UP since Jul 16th, 2024 at 50.280
The intermediate-term trend has been UP since Nov 6th, 2024 at 50.240
The short-term trend has been DOWN since Nov 14th, 2024 at 50.925
Smart Scan Analysis for MLTX
Based on our trend formula, MLTX is rated as a +75 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 49.44 | 50.98 | 48.97 | 49.90 | +0.57 |
| Prev. Close | Volume | Bid | Ask | Time |
| 49.82 | 151928 | 2024-11-20 15:59:30 |
| 52wk High | 64.98 | 52wk High Date | 2024-02-12 |
| 52wk Low | 37.55 | 52wk Low Date | 2024-06-24 |
| Average Volume | 237,624 | Shares Outstanding | 63,064 |
| Assets | 518,213,328M | Liabilities | 30,018,003M |
| P/E Ratio | -39.51610000 |